HIV-1 and methamphetamine alter galectins -1, -3, and -9 in human monocyte-derived macrophages

Kinga Grabowska1,2, Katarzyna Macur1,3, Sarah Zieschang1

  • 1Department of Pharmacology and Experimental Neuroscience, School of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Journal of Neurovirology
|February 17, 2022
PubMed

Insights

Methamphetamine alters galectin expression in HIV-1 infected macrophages. This study quantifies galectins-1, -3, and -9 in human monocyte-derived macrophages (hMDM) exposed to Meth during HIV infection.

Area of Science:

  • Immunology
  • Virology
  • Neuroscience

Background:

  • Macrophages are crucial innate immune cells.
  • HIV-1 infection in macrophages is complex and influenced by drug abuse.
  • Methamphetamine (Meth) use is common in people living with HIV and impacts cellular responses.

Purpose of the Study:

  • To investigate the impact of Meth exposure on galectin expression in HIV-1 infected human monocyte-derived macrophages (hMDM).
  • To quantify changes in intracellular and secreted galectins-1, -3, and -9.
  • To establish a foundation for understanding the molecular mechanisms of cellular pathology in hMDM.

Main Methods:

  • Utilized SWATH-MS for comprehensive quantification of galectins.
  • Employed MRM targeted mass spectrometry for validation.
  • Exposed primary hMDM to Meth before or after HIV-1 infection.

Main Results:

  • First comprehensive quantification of galectins in primary hMDM under HIV-1 infection and Meth exposure.
  • Identified dynamic changes in intracellular and secreted galectin proteomes.
  • Provided insights into Meth's influence on galectin expression in HIV-1 infected cells.

Conclusions:

  • Methamphetamine significantly alters galectin expression in HIV-1 infected macrophages.
  • This study provides crucial data on galectin dynamics in hMDM.
  • Findings pave the way for future research into HIV-1 and Meth-induced cellular pathology.

Related Concept Videos